Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study.
Vaccines (Basel). 2022 Aug 10;10(8):1290. doi: 10.3390/vaccines10081290.
Vaccines (Basel). 2022.
PMID: 36016181
Free PMC article.
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial.
Kudriavtsev AV, Vakhrusheva AV, Kryuchkov NA, Frolova ME, Blagodatskikh KA, Ivanishin TV, Djonovic M, Romanovskaya-Romanko EA, Kovalenko AN, Lioznov DA, Zubkova TG, Teplykh SV, Oseshnyuk RA, Stukova MA, Isaev AA, Krasilnikov IV.
Kudriavtsev AV, et al. Among authors: djonovic m.
Vaccines (Basel). 2023 Feb 1;11(2):326. doi: 10.3390/vaccines11020326.
Vaccines (Basel). 2023.
PMID: 36851204
Free PMC article.
Item in Clipboard
Transformative vaccination: A pentavalent shield against COVID-19 and influenza with betulin-based adjuvant for enhanced immunity.
Krasilnikov I, Isaev A, Djonovic M, Ivanov A, Romanovskaya-Romanko E, Stukova M, Zverev V.
Krasilnikov I, et al. Among authors: djonovic m.
Vaccine. 2024 Apr 2;42(9):2191-2199. doi: 10.1016/j.vaccine.2023.11.057. Epub 2024 Mar 19.
Vaccine. 2024.
PMID: 38508927
Free article.
Item in Clipboard
Cite
Cite